Agilent Announces Cell Analysis Workflow Automation for Immuno-Oncology, Virology, and Vaccine Development Markets

24.02.2023 - Agilent Technologies Inc. (NYSE: A) today announced their xCELLigence RTCA HT (real-time cell analysis high-throughput) platform now integrates with the BioTek BioSpa 8 Automated Incubator. Developed in response to market needs, this combination ...

Related Keywords

Todd Christian ,Robert Carnahan ,Agilent Technologies Inc ,Agilent Technologies ,Vanderbilt University Medical Center ,Facebook ,Vanderbilt Vaccine Center ,Agilent Cell Analysis Division ,Cell Analysis ,Vanderbilt University Medical ,Agilent Technologies Stock ,